BENZAZEPINONE CALCIUM-CHANNEL BLOCKERS .3. SYNTHESIS AND STRUCTURE ACTIVITY STUDIES OF 3-ALKYLBENZAZEPINONES

被引:30
作者
DAS, J
FLOYD, DM
KIMBALL, SD
DUFF, KJ
VU, TC
LAGO, MW
MOQUIN, RV
LEE, VG
GOUGOUTAS, JZ
MALLEY, MF
MORELAND, S
BRITTAIN, RJ
HEDBERG, SA
CUCINOTTA, GG
机构
[1] Bristol-Myers Squibb Pharmaceutical Research Institute, New Jersey 08543-4000, P.O. Box 4000, Princeton
关键词
D O I
10.1021/jm00082a019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As part of a program aimed at identifying novel analogues of diltiazem, we developed several synthetic routes for 3-alkylbenzazepinones, both in racemic and nonracemic form. Structure-activity relationship studies in this series have led to identification of several analogues as potent calcium channel blocking agents, both in vitro and in vivo. Analogues containing a 6-trifluoromethyl substituent (17a and 17b) are the most potent vasorelaxants in vitro. The oral antihypertensive activity of these compounds is comparable to its 3-acetoxy derivative 1 (X = 6-CF3) and 8-chlorodiltiazem (2b). The 3-allyl analogue 17c is a more potent antihypertensive agent than 17a, 17b, or 8-chlorodiltiazem (2b), and has a longer duration of action in vivo.
引用
收藏
页码:773 / 780
页数:8
相关论文
共 11 条
[1]   BENZAZEPINONE CALCIUM-CHANNEL BLOCKERS .2. STRUCTURE-ACTIVITY AND DRUG-METABOLISM STUDIES LEADING TO POTENT ANTIHYPERTENSIVE AGENTS - COMPARISON WITH BENZOTHIAZEPINONES [J].
FLOYD, DM ;
KIMBALL, SD ;
KRAPCHO, J ;
DAS, J ;
TURK, CF ;
MOQUIN, RV ;
LAGO, MW ;
DUFF, KJ ;
LEE, VG ;
WHITE, RE ;
RIDGEWELL, RE ;
MORELAND, S ;
BRITTAIN, RJ ;
NORMANDIN, DE ;
HEDBERG, SA ;
CUCINOTTA, GG .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) :756-772
[2]   SYNTHESIS OF BENZAZEPINONE AND 3-METHYLBENZOTHIAZEPINONE ANALOGS OF DILTIAZEM [J].
FLOYD, DM ;
MOQUIN, RV ;
ATWAL, KS ;
AHMED, SZ ;
SPERGEL, SH ;
GOUGOUTAS, JZ ;
MALLEY, MF .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (21) :5572-5579
[3]   SYNTHESIS OF HALOGEN-SUBSTITUTED 1,5-BENZOTHIAZEPINE DERIVATIVES AND THEIR VASODILATING AND HYPOTENSIVE ACTIVITIES [J].
INOUE, H ;
KONDA, M ;
HASHIYAMA, T ;
OTSUKA, H ;
TAKAHASHI, K ;
GAINO, M ;
DATE, T ;
AOE, K ;
TAKEDA, M ;
MURATA, S ;
NARITA, H ;
NAGAO, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :675-687
[4]   ABSOLUTE CONFORMATION AND CONFIGURATION OF (2S, 3S)-3-ACETOXY-5-(DIMETHYLAMINOETHYL)-2-(4-METHOXYPHENYL)-2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONE CHLORIDE (DILTHIAZEM HYDROCHLORIDE) [J].
KOJICPRODIC, B ;
RUZICTOROS, Z ;
SUNJIC, V ;
DECORTE, E ;
MOIMAS, F .
HELVETICA CHIMICA ACTA, 1984, 67 (03) :916-926
[5]  
KUGITA H, 1970, CHEM PHARM BULL, V18, P2284
[6]  
KUGITA H, 1971, CHEM PHARM BULL, V19, P595
[7]  
LEBOEUF E, 1987, DRUG METAB DISPOS, V15, P122
[8]  
MAIN P, 1978, MULTAN SYSTEM COMPUT
[9]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF DILTIAZEM AND ITS MAJOR METABOLITES, N-MONODEMETHYLDILTIAZEM AND DESACETYLDILTIAZEM, IN PLASMA [J].
MONTAMAT, SC ;
ABERNETHY, DR ;
MITCHELL, JR .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 415 (01) :203-207
[10]  
NAGAO T, 1973, CHEM PHARM BULL, V21, P92